Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings

Kengo Tanabe; Angela Hoye; Pedro A. Lemos; Jiro Aoki; Chourmouzios A. Arampatzis; Francesco Saia; Chi Hang Lee; Muzzafer Degertekin; Sjoerd H. Hofma; Georgios Sianos; Eugene McFadden; Pieter C. Smits; Willem J. Van Der Giessen; Pim De Feyter; Ron T. Van Domburg; Patrick W. Serruys

doi:10.1016/j.amjcard.2004.03.040

Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings

Kengo Tanabe
, Angela Hoye
, Pedro A. Lemos
, Jiro Aoki
, Chourmouzios A. Arampatzis
, Francesco Saia
, Chi Hang Lee
, Muzzafer Degertekin
, Sjoerd H. Hofma
, Georgios Sianos
, Eugene McFadden
, Pieter C. Smits
, Willem J. Van Der Giessen
, Pim De Feyter
, Ron T. Van Domburg
, Patrick W. Serruys

Erasmus MC

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

149 Citations (Scopus)

Abstract

The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.

Original language	English
Pages (from-to)	115-118
Number of pages	4
Journal	American Journal of Cardiology
Volume	94
Issue number	1
DOIs	https://doi.org/10.1016/j.amjcard.2004.03.040
Publication status	Published - 1 Jul 2004
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.amjcard.2004.03.040

Cite this

Tanabe, K., Hoye, A., Lemos, P. A., Aoki, J., Arampatzis, C. A., Saia, F., Lee, C. H., Degertekin, M., Hofma, S. H., Sianos, G., McFadden, E., Smits, P. C., Van Der Giessen, W. J., De Feyter, P., Van Domburg, R. T., & Serruys, P. W. (2004). Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. American Journal of Cardiology, 94(1), 115-118. https://doi.org/10.1016/j.amjcard.2004.03.040

@article{2023d2b61960475684a9d0efaeeaaa6c,

title = "Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings",

abstract = "The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3\% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.",

author = "Kengo Tanabe and Angela Hoye and Lemos, \{Pedro A.\} and Jiro Aoki and Arampatzis, \{Chourmouzios A.\} and Francesco Saia and Lee, \{Chi Hang\} and Muzzafer Degertekin and Hofma, \{Sjoerd H.\} and Georgios Sianos and Eugene McFadden and Smits, \{Pieter C.\} and \{Van Der Giessen\}, \{Willem J.\} and \{De Feyter\}, Pim and \{Van Domburg\}, \{Ron T.\} and Serruys, \{Patrick W.\}",

year = "2004",

month = jul,

day = "1",

doi = "10.1016/j.amjcard.2004.03.040",

language = "English",

volume = "94",

pages = "115--118",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "1",

}

Tanabe, K, Hoye, A, Lemos, PA, Aoki, J, Arampatzis, CA, Saia, F, Lee, CH, Degertekin, M, Hofma, SH, Sianos, G, McFadden, E, Smits, PC, Van Der Giessen, WJ, De Feyter, P, Van Domburg, RT & Serruys, PW 2004, 'Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings', American Journal of Cardiology, vol. 94, no. 1, pp. 115-118. https://doi.org/10.1016/j.amjcard.2004.03.040

TY - JOUR

T1 - Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings

AU - Tanabe, Kengo

AU - Hoye, Angela

AU - Lemos, Pedro A.

AU - Aoki, Jiro

AU - Arampatzis, Chourmouzios A.

AU - Saia, Francesco

AU - Lee, Chi Hang

AU - Degertekin, Muzzafer

AU - Hofma, Sjoerd H.

AU - Sianos, Georgios

AU - McFadden, Eugene

AU - Smits, Pieter C.

AU - Van Der Giessen, Willem J.

AU - De Feyter, Pim

AU - Van Domburg, Ron T.

AU - Serruys, Patrick W.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.

AB - The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.

UR - https://www.scopus.com/pages/publications/3042517140

U2 - 10.1016/j.amjcard.2004.03.040

DO - 10.1016/j.amjcard.2004.03.040

M3 - Article

C2 - 15219520

AN - SCOPUS:3042517140

SN - 0002-9149

VL - 94

SP - 115

EP - 118

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 1

ER -

Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this